BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29665276)

  • 1. Engineered Hsp Protein Nanocages for siRNA Delivery.
    Guan X; Chang Y; Sun J; Song J; Xie Y
    Macromol Biosci; 2018 May; 18(5):e1800013. PubMed ID: 29665276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioengineered Protein Nanocage by Small Heat Shock Proteins Delivering mTERT siRNA for Enhanced Colorectal Cancer Suppression.
    Wang H; Liu N; Yang F; Hu N; Wang M; Cui M; Bruns N; Guan X
    ACS Appl Bio Mater; 2022 Mar; 5(3):1330-1340. PubMed ID: 35234441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFP-Based Protein Nanoparticles with Cell-Penetrating Peptide for Efficient siRNA Delivery.
    Guan X; Hu X; Cui F; Li Y; Jing X; Xie Z
    Macromol Biosci; 2015 Nov; 15(11):1484-9. PubMed ID: 26109167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendrimer Nanovectors for SiRNA Delivery.
    Liu X; Peng L
    Methods Mol Biol; 2016; 1364():127-42. PubMed ID: 26472447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan Nanoparticles for SiRNA Delivery In Vitro.
    Ragelle H; Vanvarenberg K; Vandermeulen G; Préat V
    Methods Mol Biol; 2016; 1364():143-50. PubMed ID: 26472448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR4-targeted modular peptide carriers for efficient anti-VEGF siRNA delivery.
    Egorova A; Shubina A; Sokolov D; Selkov S; Baranov V; Kiselev A
    Int J Pharm; 2016 Dec; 515(1-2):431-440. PubMed ID: 27789364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-specific delivery of siRNA using supramolecular assembly of hyaluronic acid nanoparticles and 2b RNA-binding protein/siRNA complexes.
    Choi KM; Jang M; Kim JH; Ahn HJ
    Biomaterials; 2014 Aug; 35(25):7121-32. PubMed ID: 24854094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycerol monooleate-based nanocarriers for siRNA delivery in vitro.
    Zhen G; Hinton TM; Muir BW; Shi S; Tizard M; McLean KM; Hartley PG; Gunatillake P
    Mol Pharm; 2012 Sep; 9(9):2450-7. PubMed ID: 22794355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.
    Ku SH; Kim K; Choi K; Kim SH; Kwon IC
    Adv Healthc Mater; 2014 Aug; 3(8):1182-93. PubMed ID: 24577795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of osteoclastogenesis through siRNA delivery with tunable mesoporous bioactive nanocarriers.
    Kim TH; Singh RK; Kang MS; Kim JH; Kim HW
    Acta Biomater; 2016 Jan; 29():352-364. PubMed ID: 26432439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
    Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y
    Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of siRNA Complexed with Palmitoylated α-Peptide/β-Peptoid Cell-Penetrating Peptidomimetics: Membrane Interaction and Structural Characterization of a Lipid-Based Nanocarrier System.
    Jing X; Foged C; Martin-Bertelsen B; Yaghmur A; Knapp KM; Malmsten M; Franzyk H; Nielsen HM
    Mol Pharm; 2016 Jun; 13(6):1739-49. PubMed ID: 26654841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
    Wang XL; Xu R; Lu ZR
    J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescent carbon dots as an efficient siRNA nanocarrier for its interference therapy in gastric cancer cells.
    Wang Q; Zhang C; Shen G; Liu H; Fu H; Cui D
    J Nanobiotechnology; 2014 Dec; 12():58. PubMed ID: 25547381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triblock copolymer-encapsulated nanoparticles with outstanding colloidal stability for siRNA delivery.
    Qian J; Gao X
    ACS Appl Mater Interfaces; 2013 Apr; 5(8):2845-52. PubMed ID: 23320382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symbiotic Self-Assembly Strategy toward Lipid-Encased Cross-Linked Polymer Nanoparticles for Efficient Gene Silencing.
    Dutta K; Bochicchio D; Ribbe AE; Alfandari D; Mager J; Pavan GM; Thayumanavan S
    ACS Appl Mater Interfaces; 2019 Jul; 11(28):24971-24983. PubMed ID: 31264399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in the size of layered double hydroxide nanoparticles enhances the efficiency of siRNA delivery.
    Chen M; Cooper HM; Zhou JZ; Bartlett PF; Xu ZP
    J Colloid Interface Sci; 2013 Jan; 390(1):275-81. PubMed ID: 23084868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic peptide-based nanostructures as efficient siRNA carriers.
    Panigrahi B; Singh RK; Mishra S; Mandal D
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S763-S773. PubMed ID: 30311806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of multimeric siRNA conjugates for efficient protamine-based delivery into breast cancer cells.
    Yoo H; Mok H
    Arch Pharm Res; 2015 Jan; 38(1):129-36. PubMed ID: 24687259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysosomal escaped protein nanocarriers for nuclear-targeted siRNA delivery.
    Cao X; Shang X; Guo Y; Zheng X; Li W; Wu D; Sun L; Mu S; Guo C
    Anal Bioanal Chem; 2021 May; 413(13):3493-3499. PubMed ID: 33770206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.